AURA (STOCKS)
Aura Biosciences, Inc. Common Stock
$7.650000
-0.100000 (-1.29%)
Prev close: $7.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Natalie C. Holles
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $871.64M
- Employees
- 106
- P/E (TTM)
- -4.30
- P/B (TTM)
- 2.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.50 | $-0.41 | -0.0945 | -23.30% |
|
Dec 2025 (Q4)
|
$-0.37 | $-0.44 | +0.0661 | +15.16% |
|
Sep 2025 (Q3)
|
$-0.40 | $-0.48 | +0.0758 | +15.93% |
|
Jun 2025 (Q2)
|
$-0.47 | $-0.47 | -0.0033 | -0.71% |
Financial Statements
| Nonoperating Income/Loss | $7.15M |
| Research and Development | $102.78M |
| Operating Income/Loss | -$138.08M |
| Income/Loss From Continuing Operations After Tax | -$131.01M |
| Income/Loss From Continuing Operations Before Tax | -$130.93M |
| Income Tax Expense/Benefit | $80.00K |
| Interest Income/Expense After Provision For Losses | $6.86M |
| Net Income/Loss | -$131.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$131.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$131.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.75 |
| Diluted Earnings Per Share | -$1.75 |
| Basic Average Shares | 149,421,409 |
| Diluted Average Shares | 149,421,409 |
| Assets | $348.13M |
| Current Assets | $329.03M |
| Noncurrent Assets | $19.10M |
| Fixed Assets | $2.20M |
| Other Non-current Assets | $16.90M |
| Liabilities | $32.86M |
| Current Liabilities | $19.56M |
| Accounts Payable | $2.25M |
| Other Current Liabilities | $17.31M |
| Noncurrent Liabilities | $13.30M |
| Equity | $315.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $315.27M |
| Liabilities And Equity | $348.13M |
| Net Cash Flow From Operating Activities | -$103.01M |
| Net Cash Flow From Operating Activities, Continuing | -$103.01M |
| Net Cash Flow From Investing Activities | -$185.33M |
| Net Cash Flow From Investing Activities, Continuing | -$185.33M |
| Net Cash Flow From Financing Activities | $249.18M |
| Net Cash Flow From Financing Activities, Continuing | $249.18M |
| Net Cash Flow | -$39.16M |
| Net Cash Flow, Continuing | -$39.16M |
| Comprehensive Income/Loss | -$131.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$131.71M |
| Other Comprehensive Income/Loss | -$26.83M |
| Other Comprehensive Income/Loss Attributable To Parent | -$695.00K |